Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (441-450 of 659) with videos related to

Pageof 66
Sort By:
Journal of Medical Microbiology|June 17, 2009
In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilmsRobin K Pettit, Christine A Weber, Stacey B Lawrence, et al.
Cancer Research|June 15, 1993
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activityR L Berkow, L Schlabach, R Dodson, et al.
Anti-Cancer Drugs|February 1, 1993
In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub)A A el-Zayat, D Degen, S Drabek, et al.
Cancer Research|March 1, 1987
Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1aZ Kiss, E Deli, M Shoji, et al.
Anti-Cancer Drug Design|February 25, 1998
Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modificationsG R Pettit, E J Flahive, M R Boyd, et al.
International Journal of Oncology|July 13, 1999
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft modelR M Mohammad, C Limvarapuss, N R Wall, et al.
The American Journal of Psychiatry|March 1, 1994
Long-term follow-up of 85 patients with obsessive-compulsive disorderL M Orloff, M A Battle, L Baer, et al.
Carcinogenesis|April 1, 1988
Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitroM Gschwendt, G Fürstenberger, S Rose-John, et al.
Biochemistry|August 1, 1995
The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domainR Bai, G F Taylor, Z A Cichacz, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
A new anti-tubulin agent containing the benzo[b]thiophene ring systemK G Pinney, A D Bounds, K M Dingeman, et al.
Pageof 66

Showing results (441-450 of 659) with videos related to

Sort By:
Pageof 66
Journal of Medical Microbiology|June 17, 2009
In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilmsRobin K Pettit, Christine A Weber, Stacey B Lawrence, et al.
Cancer Research|June 15, 1993
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activityR L Berkow, L Schlabach, R Dodson, et al.
Anti-Cancer Drugs|February 1, 1993
In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub)A A el-Zayat, D Degen, S Drabek, et al.
Cancer Research|March 1, 1987
Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1aZ Kiss, E Deli, M Shoji, et al.
Anti-Cancer Drug Design|February 25, 1998
Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modificationsG R Pettit, E J Flahive, M R Boyd, et al.
International Journal of Oncology|July 13, 1999
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft modelR M Mohammad, C Limvarapuss, N R Wall, et al.
The American Journal of Psychiatry|March 1, 1994
Long-term follow-up of 85 patients with obsessive-compulsive disorderL M Orloff, M A Battle, L Baer, et al.
Carcinogenesis|April 1, 1988
Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitroM Gschwendt, G Fürstenberger, S Rose-John, et al.
Biochemistry|August 1, 1995
The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domainR Bai, G F Taylor, Z A Cichacz, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
A new anti-tubulin agent containing the benzo[b]thiophene ring systemK G Pinney, A D Bounds, K M Dingeman, et al.
Pageof 66